switching from tirzepatide to semaglutide dosing Tirzepatide: Is It a Good Idea? switching from tirzepatide to semaglutide

This weight loss medicine has been available in the United States since 2022 for treating diabetes, and was approved in 2023 under the brand name Zepbound for use in weight management alongside a reduced calorie diet and increased physical activity

Losing weight can reduce the risk of heart disease, improve mobility, and increase energy levels

Aviles-Olmos I, Dickson J, Kefalopoulou Z, Djamshidian A, Kahan J, Ell P, Whitton P, Wyse R, Isaacs T, Lees A, et al

Total weight loss (TWL%) was 10.8% in the whole cohort

The study in JAMA is in opposition to another recent analysis which showed a decrease, says obesity expert and lipid specialist Dr